MoonLake Immunotherapeuti... (MLTX)

NASDAQ: MLTX · Real-Time Price · USD

42.05

1.87 (4.65%)

At close: Apr 30, 2025, 3:59 PM

43.00

2.26%

After-hours: Apr 30, 2025, 04:11 PM EDT

MoonLake Immunotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	180.43M	375.66M	342.79M	458.44M	451.17M	318.17M	501.79M	50.13M	39.51M	41.2M	92.71M	101.02M	8.04M	1.03M	1.1M	1.17M	n/a
Short-Term Investments	267.6B	118.27M	177.01M	88.61M	59.84M	177.81M	n/a	12.92M	32.61M	42.25M	n/a	n/a	n/a	n/a	n/a	115.01M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	115.05M	115.04M	115.04M	115.04M	115.03M	n/a
Other Long-Term Assets	3.64B	2.06M	4.13M	6.32M	8.42M	n/a	n/a	0.00	n/a	n/a	n/a	-59.26K	-115.04M	-29.85K	n/a	n/a	n/a
Receivables	2.84M	2.41M	1.68M	1.5M	1.06M	720.75K	619.77K	378.44K	217.13K	600.54K	557.05K	15M	148.77K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	23.42B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	474.29B	512.32M	536.88M	553.59M	514.17M	500.01M	506.37M	66.5M	76.51M	88.54M	98.38M	116.16M	9.64M	1.21M	1.33M	1.46M	n/a
Property-Plant & Equipment	3.64M	3.83M	3.87M	4.21M	3.95M	208.94K	254.05K	292.36K	331.97K	52.68K	55.97K	59.26K	45.74K	29.85K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.64B	5.9M	8M	10.53M	12.37M	208.94K	254.05K	292.36K	331.97K	52.68K	55.97K	115.05M	45.74K	115.04M	115.04M	115.03M	n/a
Total Assets	477.93B	518.21M	544.88M	564.12M	526.54M	500.22M	506.62M	66.8M	76.84M	88.59M	98.43M	231.21M	9.68M	116.25M	116.37M	116.49M	n/a
Account Payables	8.68M	104.32K	55.98K	1.63M	553.46K	824.07K	270.75K	510.52K	65.98K	155.53K	246.75K	213.45K	1.23M	95.66K	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	563K	-778.22K	-185.48K	n/a	-270.75K	n/a	n/a	n/a	n/a	-213.45K	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	1.32M	n/a	n/a	n/a	158.22K	155.17K	n/a	n/a	n/a	15.15M	15M	n/a	n/a	n/a	n/a
Other Current Liabilities	22.45B	2.92M	7.5M	1.05M	259.73K	2.76M	745.86K	4.23M	1.11M	217.14K	1.81M	182.57M	1.3M	-1.54M	90K	60K	n/a
Total Current Liabilities	22.46B	20.08M	12.28M	8.91M	9.97M	10.31M	7.13M	7.28M	7.67M	6.02M	3.86M	202.79M	21.09M	2.06M	90K	60K	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.08B	694.96K	541.95K	462.74K	583.42K	255.4K	323.6K	314.17K	282.21K	4.99K	18.59K	4.03M	239.86K	4.03M	4.03M	4.03M	n/a
Total Long-Term Liabilities	2.08B	2.63M	2.56M	2.82M	3.08M	268.48K	376.61K	405.25K	411.16K	4.99K	18.59K	4.02M	239.86K	4.03M	4.03M	4.03M	n/a
Total Liabilities	24.54B	22.71M	14.85M	11.73M	13.05M	10.58M	7.51M	7.68M	8.08M	6.02M	3.88M	206.82M	21.33M	6.08M	4.12M	4.08M	n/a
Total Debt	2.83M	3.69M	3.34M	3.66M	3.7M	169.42K	211.24K	246.25K	282.58K	n/a	n/a	15.15M	15M	n/a	n/a	n/a	n/a
Common Stock	6.39K	6.39K	6.39K	6.39K	6.3K	6.25K	6.25K	5.27K	5.27K	5.27K	5.27K	673.00	38.54K	115M	107.26M	107.41M	n/a
Retained Earnings	-235.59B	-189.99M	-154.6M	-130.33M	-116.66M	-109.22M	-99.79M	-89.66M	-80.65M	-68.79M	-58.68M	-9.76M	-53.64M	-4.84M	-319.46K	-167.13K	n/a
Comprehensive Income	5M	2.83M	3.26M	2.69M	2.36M	2.88M	35.12K	340.11K	350.95K	245.28K	133.72K	98.09K	-168.18K	0.00	n/a	n/a	n/a
Shareholders Equity	446.83B	488.2M	520.66M	542.55M	495.68M	424.93M	489.8M	42M	48.9M	55.29M	63.51M	24.4M	-11.65M	110.16M	112.26M	112.41M	n/a
Total Investments	267.6B	118.27M	177.01M	88.61M	59.84M	177.81M	n/a	12.92M	32.61M	42.25M	n/a	115.05M	115.04M	115.04M	115.04M	115.03M	n/a